跳至主要内容
临床试验/NCT00199953
NCT00199953已完成2 期

Post-nasal Drainage as an Extraesophageal Manifestation of Reflux

Medical College of Wisconsin2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2002年6月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
2
主要终点
- VAS1:Visual Analog Scale indicating severity of PND

研究概览

简要总结

Objectives of this study are:

  • To quantitatively evaluate the relationship between extraesophageal manifestations of gastroesophageal reflux (EER) and postnasal drainage(PND)in a group of patients without radiographic or endoscopic evidence of sinonasal inflammatory disease.
  • To assess the efficacy of BID proton pump inhibitors (PPI) in the management of patients with symptomatic postnasal drainage.

详细描述

Gastroesophageal reflux disease(GERD) is a common disorder of the esophagus, affecting 7-10% of the U.S. population. Characteristic symptoms include heartburn, chest pain, and indigestion. EER denotes gastroesophageal refluxate that reaches structures above the upper esophageal sphincter. EER has been implicated in the pathogenesis of several otolaryngologic disorders such as chronic posterior laryngitis, laryngeal contact ulcer or granuloma, paroxysmal laryngospasm, vocal cord nodules, Reinke's edema, subglottic or laryngotracheal stenosis, globus pharyngeus,and laryngeal and hypopharyngeal carcinoma. In addition, EER has been associated with disorders of both the lower and upper respiratory tract and with chronic sinonasal inflammation.

Patients with EER rarely complain of the common symptoms of GERD, such as heartburn. Often they present with symptoms involving the larynx and pharynx, including throat-clearing, globus pharyngeus, and postnasal drainage. These symptoms may be present due to direct irritation of the nasal epithelium by gastric refluxate and/or a neurogenic inflammatory process mediated by the autonomic nervous system.

Specific Aims:

  • Specific Aim 1: To establish the relation ship between EER and PND in patients without sinonasal inflammatory disease.
  • Hypothesis 1: In patients without radiographic or endoscopic evidence of sinonasal inflammatory disease, PND is a symptom of EER.
  • Method 1: We will test this hypothesis utilizing a 2-site 24-hour pH probe test in a symptomatic patient group and compare then to a previously tested age and sex-matched control group.
  • Specific Aim 2: To establish the efficacy of PPI in the management of PND.
  • Hypothesis 2: Patients with a chief complaint of PND and no sinonasal inflammatory disease will improve with 3-month PPI treatment with Rabeprazole 20 mg twice a day.
  • Method 2: A group of patients with a chief complaint of postnasal drainage, without radiographic or endoscopic evidence of sinonasal inflammatory disease will be entered into a prospective placebo-controlled trial utilizing BID PPIs over a 3-month period. the primary outcome measures will be: 1) Visual analog Scales, assessing the severity and frequency of PND at days 0 and 90 of treatment and 2)A quantitative color analysis of laryngeal erythema, utilizing videolaryngoscopy at days 0 and 90 of treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 and <70;
  • PND as chief complaint;
  • No known acute or chronic sinus disease;
  • Nonsmokers;
  • Subjects with no history of esophageal or gastric surgery
  • Subjects with no history of allergic disease
  • Women non pregnant.

排除标准

  • Age , 18 or > 70;
  • No PND as chief complaint
  • Al;ergic disease or acute or chronic sinus disease;
  • Pregnant women;
  • Subjects with history of esophageal or gastric surgery

结局指标

主要结局

- VAS1:Visual Analog Scale indicating severity of PND

- VAS2:Visual Analog Scale indicating frequency of PND

- VAS3:Visual Analog Scale indicating frequency of throat-clearing.

次要结局

  • - Two-site 24-hour pH probe test indicating presence or gastroesophageal reflux episodes.
  • - Videolaryngoscopy for quantitative color analysis evaluation of laryngeal erythema as index of EER.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验